CathWorks Announces First Patient Enrolled in Global ALL-RISE Study
CathWorks announced today that the first patient has been enrolled in the Advancing Cath Lab Results with FFRangio Coronary Physiology Assessment (ALL-RISE) Study.
CathWorks FFRangio® System:
A New Era in Coronary Physiology
The FFRangio System combines artificial intelligence and advanced computational science to obtain physiologic information from routine angiograms to better inform treatment decisions. Now, interventional cardiologists in the cath lab can quickly get more insight with less hassle.